Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
BD Announces Results for 2011 Second Fiscal Quarter
Date:4/26/2011
.0)Net income (1)
$
2.74
$
2.538.3AVERAGE SHARES OUTSTANDINGBasic224,528236,353Diluted229,529242,327NM - Not Meaningful(1) Total per share amounts may not add due to roundingBECTON DICKINSON AND COMPANYSUPPLEMENTAL REVENUE INFORMATIONREVENUES BY SEGMENT AND GEOGRAPHIC AREA(Unaudited; Amounts in thousands)Three Months Ended March 31,20112010% ChangeBD MEDICAL United States
$
398,487
$
381,7674.4 International582,845539,8668.0TOTAL
$
981,332
$
921,6336.5BD DIAGNOSTICS United States
$
310,617
$
292,8416.1 International294,730262,83112.1TOTAL
$
605,347
$
555,6728.9BD BIOSCIENCES United States
$
120,077
$
117,1512.5 International215,267204,9535.0TOTAL
$
335,344
$
322,1044.1TOTAL REVENUES United States
$
829,181
$
791,7594.7 International1,092,8421,007,6508.5TOTAL
$
1,922,023
$
1,799,4096.8BECTON DICKINSON AND COMPANYSUPPLEMENTAL REVENUE INFORMATIONREVENUES BY SEGMENT AND GEOGRAPHIC AREA(Unaudited; Amounts in thousands)Six Months Ended March 31,20112010% ChangeBD MEDICAL United States
$
804,014
$
814,344(1.3) International1,103,8631,077,9592.4TOTAL
$
1,907,877
$
1,892,3030.8BD DIAGNOSTICS United States
$
619,467
$
603,0452.7 International587,603548,1027.2TOTAL
$
1,207,070
$
1,151,1474.9BD BIOSCIENCES United States
$
234,302
$
227,7872.9 International414,779396,9904.5TOTAL
$
649,081
$
624,7773.9TOTAL REVENUES United States
$
1,657,783
$
1,645,1760.8 International2,106,2452,023,0514.1TOTAL
$
3,764
'/>"/>
| SOURCE BD (Becton, Dickinson and Company) Copyright©2010 PR Newswire. All rights reserved |
Related medicine technology :
1. Rochester Medical Announces Second Quarter 2011 Earnings Conference Call Thursday, May 5, 2011
2. Central European Society for Anticancer Drug Research Announces Start of Enrollment in First Randomized Trial of Pharmacokinetic-Guided Dose Adjustment of Paclitaxel in Non-Small Cell Lung Cancer
3. Novavax Announces Senior Management Appointments
4. Roper Industries Announces Record First Quarter Results
5. Accuray Incorporated Announces HSR Clearance in Acquisition of TomoTherapy
6. Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events
7. HemaQuest Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease
8. Express Scripts Announces Intention to Commence a Debt Offering
9. ConvaTec Healthcare Announces 2010 Year-End Earnings Call
10. Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System
11. KemPharm, Inc. Announces Plans to Launch KP106 as First Oral Film Dosage Form for ADHD
Post Your Comments:
(Date:5/17/2013)... May 17, 2013 Shareholder rights attorneys at ... Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has filed a complaint ... Massachusetts . The complaint alleges that ... Exchange Act of 1934 (the "Exchange Act") between January ... (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...
(Date:5/17/2013)... TechAtlas Group has announced the release of ... for the Chronic Kidney Disease (CKD) market. This ... drugs and devices currently on the market and ... (Logo: http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) ... renal denervation , diabetic nephropathy - antifibrotics ...
(Date:5/17/2013)... , May 17, 2013 Boehringer Ingelheim ... respiratory disease at the American Thoracic Society International ... , May 17 – 22. ... approved for the treatment of chronic obstructive pulmonary ... as well as investigational compounds for asthma, idiopathic ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8... Inc. (Nasdaq: BMRN ) today announced that ... a conference call and webcast on Thursday, July 28, ... financial results. U.S. / Canada Dial-in Number: ... Participant Code: 79527137 Replay Dial-in Number: 888.286.8010 ...
... 30, 2011 Endo Pharmaceuticals (Nasdaq: ENDP ) ... the novel investigational drug axomadol against placebo in the treatment ... The results indicate that axomadol did not meet predetermined study ... the data and evaluating the path forward for the program. ...
Cached Medicine Technology:BioMarin to Host Second Quarter 2011 Financial Results Conference Call and Webcast on Thursday, July 28 at 5:00 p.m. ET 2Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain 2(Date:5/18/2013)... (PRWEB) May 19, 2013 Illuminations is proud ... Trisha Caetano. Seminars will take place over the course ... Friday, June 7, and Saturday, June 8, 2013. , Inner ... symptoms, but focuses on the attitudes, patterns and coping mechanisms ... symptoms. Participants will learn to live a more integrated and ...
(Date:5/18/2013)... few extra cups of coffee each month might help ... as primary sclerosing cholangitis (PSC), a new study suggests. ... found that drinking coffee was associated with a reduced ... cirrhosis of the liver, liver failure and biliary cancer. ... "While rare, PSC has extremely detrimental effects," ...
(Date:5/18/2013)... FL (May 18, 2013) There are significant ... commonly used to diagnose or treat gastrointestinal problems, ... (DDW). , A study by New York ... more objective testing may substantially reduce the cost ... Although GERD is believed to affect nearly 25 ...
(Date:5/18/2013)... Hayden, ID (PRWEB) May 18, 2013 ... needs when it comes to safety and comfort ... these requirements and provides clients with an effective ... System®. This is an integrated, turnkey communications ... of care, while allowing residents independence and privacy. ...
(Date:5/18/2013)... York (PRWEB) May 18, 2013 ... mesh products continue to move forward in a consolidated ... Bernstein Liebhard LLP reports. According to a notice on ... the Ethicon pelvic mesh litigation will be held on ... complaints have been filed in the proceeding on behalf ...
Breaking Medicine News(10 mins):Health News:Illuminations Brings World Renowned Therapist to the Middle East 2Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3[0] Illuminations Brings World Renowned Therapist to the Middle East[0] Study Links Coffee to Lower Risk for Rare Liver Disease[0] New research identifies practice changes to improve value and quality of GI procedures[0] VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities[0] Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation
... (Dec. 11, 2007) -- In as many as one ... contracts to send blood around the body, some degree ... condition known as mitral regurgitation (MR). When sufficiently severe, ... to difficulty in breathing (dyspnea, or "shortness of breath"), ...
... play harder and longer when their child care centers ... ropes and riding toys), more opportunities for active play ... students, according to a study published in the January ... Researchers at the University of North Carolina School of ...
... one of the newest classes of cancer treatments has been ... what else to give patients when this happens. , The ... cells develop resistance and to have forward-thinking strategies about how ... in the laboratory of Dr. Kapil Bhalla, director of the ...
... for Methods of Cloning Livestock From,Differentiated Donor Cells, ... Inc.,(Start) announced today that the U.S. Patent and ... 7,307,198 covering methods of,cloning ungulate animals, fetuses and ... of a portfolio of patents and patent,applications owned ...
... Vaccination Into the New Year, BETHESDA, Md., ... full swing, getting vaccinated against influenza, commonly known ... you and your family healthy. Too many,people think ... October and,November, but the National Foundation for Infectious ...
... LIVINGSTON, N.J., Dec. 11 MM2 Group, ... wholly-owned,subsidiary, Genotec Nutritionals, Inc., a New York based ... of its branded,products and through custom formulations for ... order for a new product featuring high,potency odorless ...
Cached Medicine News:Health News:Exercise testing may help predict seriousness of mitral regurgitation 2Health News:Kids more active when playground has balls, jump ropes, UNC study shows 2Health News:Cancer cell line developed that is resistant to new cancer therapy 2Health News:Start Licensing, Inc. Further Strengthens Position in Cloning Industry With New Patents 2Health News:Don't Let Influenza Ruin Your Holidays - Get Vaccinated 2Health News:Don't Let Influenza Ruin Your Holidays - Get Vaccinated 3Health News:MM2 Group Closes Sale for New Fish Oil Product 2Health News:MM2 Group Closes Sale for New Fish Oil Product 3Exercise testing may help predict seriousness of mitral regurgitationKids more active when playground has balls, jump ropes, UNC study showsCancer cell line developed that is resistant to new cancer therapyStart Licensing, Inc. Further Strengthens Position in Cloning Industry With New PatentsDon't Let Influenza Ruin Your Holidays - Get VaccinatedMM2 Group Closes Sale for New Fish Oil Product
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |